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Omics approaches to the study of complex biological systems with potential applications to molecular medicine are attracting
great interest in clinical as well as in basic biological research. Genomics, transcriptomics and proteomics are characterized by
the lack of an ap r i o r ideﬁnition of scope, and this gives suﬃcient leeway for investigators (a) to discern all at once a globally
altered pattern of gene/protein expression and (b) to examine the complex interactions that regulate entire biological processes.
Twopopularplatformsin“omics”areDNAmicroarrays,which measuremessengerRNAtranscriptlevels,andproteomicanalyses,
which identify and quantify proteins. Because of their intrinsic strengths and weaknesses, no single approach can fully unravel the
complexities of fundamental biological events. However, an appropriate combination of diﬀerent tools could lead to integrative
analyses that would furnish new insights not accessible through one-dimensional datasets. In this review, we will outline some
of the challenges associated with integrative analyses relating to the changes in metabolic pathways that occur in complex
pathophysiological conditions(viz.ageing and altered thyroid state)inrelevantmetabolically activetissues.Inaddition,wediscuss
several new applications of proteomic analysis to the investigation of mitochondrial activity.
1.Introduction
Genomic and proteomic data analyses have proven to be
essential for an understanding of the underlying factors
involvedinhumandiseaseandforthediscoveryofdiagnostic
biomarkers, as well as for the provision of further insights
into the metabolic eﬀects mediated by signaling molecules.
All classes of biological compounds, from genes through
mRNA to proteins and metabolites, can be analyzed by
the respective “omic” approaches, namely, genomics, tran-
scriptomics, proteomics, or metabonomics. Such an “omic”
approach leads to a broader view of the complex biolog-
ical system, including the pathology of diseases. Indeed,
while the data obtained from genomics may explain the
disposition of diseases (i.e., increased risk of acquiring a
certain disease), several other mechanisms that are not
gene mediated may be involved in the onset of disease.
Moreover, a single gene can be processed to result in several
diﬀerent mRNAs or proteins, which directly determine
diﬀerent cellular functions. Variations in metabolite ﬂuxes,
which may be taken as the downstream result of changes
in gene expression and protein translation, may be expected
to be ampliﬁed relative to changes in the transcriptome
and proteome. However, time-dependent measurementsand
determinations of metabolite content at a single time-point
can be misleading as these ﬂuxes vary quickly. Therefore,
while genomics/transcriptomics enables assessments of all
potential information, proteomics enables us to assess the
programs that are actually executed, and metabolomics will
mostly display the results of such executions.2 Journal of Biomedicine and Biotechnology
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Figure 1: Categories and potential applications of proteomics and beneﬁts of integration of proteomics and transcriptomics in the study of
complex biological systems.
In the postgenomic era, functional analysis of genes and
their products constitutes a novel and powerful approach
since the expression levels of multiple genes and proteins
can thereby be analyzed simultaneously, in both health
and disease (Figure 1). Among the techniques used in
functional genomics, both DNA microarrays [1–3]a n d
classical and ongoing proteomic approaches (ﬁnalized to
protein separation and identiﬁcation) [4–6]h o l dg r e a t
promise for the study of complex biological systems and
have applications in molecular medicine. These technologies
allow high-throughput analysis as they are complementary
to each other, and they may lead to a better understanding of
the regulatory events involved in physiological, and disease,
processes. Proteins are excellent targets in disease diagnos-
tics, prognostics, and therapeutics. Consequently, proteomic
a p p r o a c h e s( s u c ha st w o - d i m e n s i o n a lg e le l e c t r o p h o r e s i s
(2D-E), two-dimensional liquid chromatography (2-DL),
and mass spectrometry (MS)), which allow the simultaneous
measurement and comparison of the expression levels of
hundreds of proteins, represent powerful tools for (a) the
discoveryofnovelhormone/drugtargetsandbiomarkersand
(b)studiesofcellularmetabolismandproteinexpressions[7,
8].Increasingly,proteomictechniquesarebeingadopted—in
particular, to avoid the limitations inherent in the more clas-
sical approaches—to solve analytical problems and obtain a
more comprehensive identiﬁcation and characterization of
molecular events associated with pathophysiological condi-
tions (Figure 1).
In this paper, we will discuss a variety of mainly
recent transcriptomic- and proteomic-based studies that
have provided a comprehensive mechanistic insight into two
very complex biological phenomena, namely, age-associated
muscle sarcopenia and thyroid-hormone signaling. More-
over, as mitochondria are severely aﬀected during ageing and
it is generally believed that dysfunctions of mitochondria
also cause ageing and muscle sarcopenia, we will also discuss
proteomic analysis of the alterations in rat skeletal muscle
mitochondria caused by ageing.
2. Ageing Sarcopenia
Ageing, one of the most complex biological phenomena,
is a multifaceted process in which several physiological
changes occur at both the tissue and the whole-organism
level. Indeed, the age-associated decline in the healthy
functioning of multiple organs/systems leads to an increased
incidence of, and mortality from, diseases such as type II
diabetes mellitus, neurodegenerative diseases, cancer, and
cardiovascular disease [9].
One of the major engagements of gerontology is the
understanding of the complex mechanisms involved in
ageing at the molecular, cellular, and organ levels that would
facilitate our understanding of age-related diseases. Research
in this area has accelerated with the application of high-
throughput technologies such as microarrays. To judge from
such studies, several metabolic pathways are aﬀected during
ageing, and the picture becomes even more complex when
we realize that most of them are interconnected.
Sarcopenia, the age-related decline in skeletal muscle
mass and strength, is a major complication in the elderly
[10, 11]. Since skeletal muscle represents the most abundant
tissue in the body, ﬁber degeneration has severe conse-
quences for posture, movement, the overall integration of
metabolism, and heat homeostasis [12]. Although various
metabolic and functional defects in ageing muscle have been
described over the last decade, senescence-related muscle
wasting is not well understood at the molecular and cellular
levels. Consequently, no eﬀective treatment has yet been
developed to counteract age-related ﬁber degeneration [13].
Over the last decades, an attractive approach to the
understanding of the molecular mechanisms involved inJournal of Biomedicine and Biotechnology 3
Table 1: Summaryof themodels used and of themajor ﬁndings obtained by applying microarraytechnologies to thestudyofageing skeletal
muscle.
Authors Experimental model Number of
analyzed genes Identiﬁed aﬀected pathways
Mouse
Lee et al., 1999 [25] Studied tissue: aged skeletal
muscle. 6347 Stress response, energy metabolism.
Rat
Sreekumar et al.,
2002 [28]
12-months-old
Sprague-Dawley rats.
Studied tissue: gastrocnemius
muscle.
800
Energy metabolism, signal transduction, stress
response, glucose/lipid metabolism, and
structural/contractile function.
Altun et al., 2007
[29]
4- and 30-months-old rats.
Studied tissue: gastrocnemius
muscle.
6240 Redox homeostasis, iron load, regulation of contractile
proteins, glycolysis, and oxidative phosphorylation.
Lombardi et al.,
2009 [26]
3- and 24-months-old rats.
Studied tissue: gastrocnemius
muscle.
1176 Energy metabolism, mitochondrial pathways,
myoﬁbrillar ﬁlaments, and detoxiﬁcation.
Human
Welle et al., 2003
[23]
21–27 yr of age and 67–75 yr
of age.
Studied tissue: vastus lateralis
muscle.
44 000
Cell cycle/cell growth, inﬂammation, signal
transduction, protein metabolism, transcription, stress
response/DNA repair, energy metabolism, and
hormonal.
Welle et al., 2004
[19]
20–29 yr of age and 65–71 yr
of age, women.
Studied tissue: vastus lateralis
muscle.
1000 Stress response/DNA repair, energy metabolism.
Zahn et al., 2006
[21]
16 and 89 yr of age.
Studied tissue: skeletal muscle. 54 675
Electron transport chain, cell cycle/cell growth,
extracellular matrix, chloride transport, complement
activation, ribosomes.
sarcopenia has been to screen all genetic pathways at one
time, by the use of full-genome oligonucleotide chips,
as well as the entire protein complement, by the use of
using proteomic tools. These approaches, when applied
together to the multifactorial muscle-wasting pathology
observed in aged ﬁbers, have allowed the identiﬁcation of
a variety of molecular and cellular changes. These include
increased oxidative stress, mitochondrial abnormalities, dis-
turbed microcirculation, hormonal imbalance, incomplete
ion homeostasis, denervation, and impaired excitation-
contraction coupling, as well as a decreased regenerative
potential (see, Sections 2.1 and 2.2). In addition, altered
posttranslational modiﬁcations, such as tyrosine nitration,
glycosylation, and phosphorylation, were recently described
as occurring in an age-related manner in numerous skeletal
muscle proteins (see, Section 2.3).
2.1. Transcriptomic Analysis Pertaining to Ageing Skeletal
Muscle. Knowledge of diﬀerential mRNA expressions (i.e.,
the transcriptome) constitutes the ﬁrst essential level of
information when studying integrated cell functions and
cell-speciﬁc gene-expression proﬁles. Since the development
ofDNAmicroarraytechnology,ithasbeenpossibletosurvey
thousandsofgenesinparallel,therebyobtaininginformation
regarding transcriptional changes on a global scale. Such
an approach has been used to study the transcriptional
alterations induced by ageing both in rodent models and
in humans. Ageing-related transcriptomic studies have been
performed both on home-spotted microarrays containing
about 4000–6000 transcripts [14–16] and on commercial
Aﬀymetrix microarrays with from 12000 [17, 18]t oa b o u t
54000 [19–26] transcripts on each array.
Concerning studies on humans, the design commonly
used involved a cross-sectional comparison of young and
elderly healthy individuals, with about eight individuals
maximum per group, or an analysis of individuals across an
age-range.Inthesestudies,severalpathwayswerehighlighted
by genes that were diﬀerentially expressed between young
(19–29 years) and elderly (65–85 years) individuals [14],
includinggenesinvolvedinenergymetabolism,thecellcycle,
signal transduction, and DNA repair [19–22].
Biological pathways found to be changed with age in
human skeletal muscle are listed in Table 1 and schematized
inFigure 2.Theyincludegenesinvolvedinthemitochondrial
electron transport chain, cell cycle, and extracellular matrix.
Zahn et al. [21], by comparing the transcriptional proﬁle
of ageing in muscle with previous transcriptional proﬁles of
ageing in the kidney [22]a n db r a i n[ 17], found a common
signature for ageing in these diverse human tissues. This
common ageing signature consists of six genetic pathways;
four display increased expression (genes in the extracellular4 Journal of Biomedicine and Biotechnology
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matrix, genes involved in cell growth, genes encoding factors
involved in complement activation, and genes encoding
components of the cytosolic ribosome) and two display
decreased expression in the aged muscle. These results
indicate that those pathways, but not necessarily individual
genes, are common elements in the age-related expression
changes among diﬀerent tissues [21]. This may imply that in
additiontotissue-speciﬁceﬀects,acommonageingsignature
may be found in any tissue that reﬂects the age of the whole
organism. This could have major implications for human
epidemiological studies, for which frequently only blood is
available.
Transcriptomic studies have been performed in labora-
tory animals using commercially available microarrays. As
in humans, the main design used for measuring changes
related to chronological age is a comparison between young
and old individuals. These studies are usually performed
on inbred strains, and so the variation between individual
animalsissmallerthanamonghumanindividuals.Therange
of tissues studied includes liver, heart, skeletal muscle, aorta,
and brain. Across all species, and in most experimental
designs there is an inﬂuence of gender on ageing features
and gene expressions [24]. Biological pathways found to be
changed with age in rodent (mouse and rat) skeletal muscle
are listed in Table 1.
Transcriptomic analysis of gastrocnemius muscle from
5- and 30-month-old male C57BL/6 mice revealed that
ageing resulted in a diﬀerential gene expression pattern [25].
Of the genes that increased in expression with age, 16%
were mediators of stress responses, including heat shock-
response genes, oxidative stress-inducible genes, and DNA
damage inducible genes (Table 1). Genes involved in energy
metabolism were downregulated with ageing, including
genes associated with mitochondrial function and turnover.
This suppression of metabolic activity was accompanied by
a concerted decline in the expressions of genes involved
in glycolysis, glycogen metabolism, and the glycerophos-
phate shunt (Table 1). Ageing was also characterized by the
induction of genes involved in neuronal growth and large
reductions in the expressions of biosynthetic enzymes.
We recently performed a transcriptomic study on gas-
trocnemius muscle from rats aged 3 months (young) and
24 months (old) via a DNA array [26]. Transcript levels for
genes associated with cellular damage were elevated in the
older muscle, while transcript levels for genes involved in
energy metabolism were reduced with age. Among the bio-
logicalclassesoftranscriptssigniﬁcantlydecreasedbyageing,
thereweretranscriptionfactorsaswellasribosomalproteins,
indicative of a lower transcription/translation activity in
old than in young skeletal muscle (Table 1). In agreement
with previous microarray studies on the skeletal muscles
of humans and rodents [18, 25, 27], we found that ageing
is accompanied by a decline in the expressions of genes
associated with energy-metabolism functions [26]( Table 1).Journal of Biomedicine and Biotechnology 5
Alterations in oxidative phosphorylation were revealed by
decreased expression levels of cytochrome c oxidase, ATPase
subunit, and carbonic anhydrase III [26]. The capacity
of mitochondria to import and oxidize fatty acids would
presumably be impaired since the mRNA levels for acylCoA
synthase as well as carnitine palmitoyl transferase 1 (CPT
1β) were reduced during ageing. Downregulation of the AK1
isoform of adenylate kinase [26] points toward decreased
AMP production and hence decreased activity of AMP-
activated protein kinase (AMPK), an inducer of glucose and
fatty acid uptake and fatty acid oxidation. Gastrocnemius
muscle from the old rats revealed increased expressions of
various factors involved in muscle diﬀerentiation toward the
“slow” phenotype (type I; oxidative ﬁbers), including p27kip
and muscle LIM protein (MLP) [26]( Table 1). As a whole,
the above data support an ageing-induced shift towards
moderate fat burning.
Ageing has been found to increase the mRNA levels of
scavengersoffreeradicalssuchasphospholipidshydroperox-
ide glutathione peroxidase and the cytosolic superoxide dis-
mutase Cu/Zn SOD (SOD1). In addition, 14-kDa ubiquitin-
conjugatingenzymeE2mRNA(acomponentofthecomplex
that adds ubiquitin to target proteins, making them capable
of destruction by the proteasome machinery) and both pro-
teasome subunit C5 and proteasome delta subunit precursor
were downregulated in aged muscle. Since the proteasome is
the major proteolytic complex responsible for the selective
degradation of oxidized proteins, these data point toward
a defective action of the proteasome. With regard to the
lysosomalpathwayofproteinbreakdown,cathepsinL(which
acts upstream of the ubiquitin-proteasome system) was also
downregulated in aged muscle [26], once again supporting a
decline in proteolysis during ageing.
The above studies have been successful in elucidating
some of the transcriptional changes that occur with age in
muscle, as well as in other tissues, and in providing insights
about age-related changes common to animals with diﬀerent
lifespans.
2.2. Proteomic Analysis Pertaining to Ageing Skeletal Muscle.
Proteomic analysis has proved valuable in informing our
understanding of the molecular mechanisms involved in the
ageing process through the identiﬁcation both of changes
in protein levels and of various posttranslational modiﬁ-
cations such as phosphorylation [30], nitration [31, 32],
and glycosylation [33] that progress with age. In order to
identify novel biomarkers of age-dependent skeletal muscle
sarcopenia, mass spectrometry-based proteomics has been
applied to the study of global muscle protein expression
patterns. Mass spectrometric peptide ﬁngerprinting, chemi-
cal peptide sequencing, electrophoretic mobility comparison
using international 2-D gel databanks, and/or large-scale
immunoblot analysis are among the most frequently utilized
techniques.
Over the last years, several proteomic studies have
catalogued the accessible skeletal muscle protein comple-
ment from various species and also investigated changes in
protein expression levels in the sarcopenia of old age. The
data obtained so far have furnished databanks that form
an important prerequisite for future large-scale proteomic
investigations into muscle ageing.
Table 2 lists proteomic studies on age-related changes
in skeletal muscle in rodent and human models of ageing.
Although the lists of individual proteins found to be aﬀected
by the ageing process diﬀer considerably between individual
proteomic surveys, the main trend of the altered proteins
involved in energy metabolism, cellular signaling, the stress
response, cytoskeleton, and contraction shows agreement
among the various studies. Gelﬁ et al. [34]p e r f o r m e da
quantitativediﬀerentialanalysisofmuscleproteinexpression
in elderly and young subjects using a 2-D DIGE approach.
The main diﬀerence observed in the elderly group included
downregulation of regulatory myosin light chains, partic-
ularly the phosphorylated isoforms, a higher proportion
of myosin heavy chain isoforms 1 and 2A, and enhanced
oxidative and reduced glycolytic capacities.
Proteomic proﬁling of rodent muscle during ageing
has been performed in several studies, resulting in the
identiﬁcation of a large cohort of sarcopenic biomarkers (for
a schema, see Figure 2).
Age-dependent diﬀerential regulation in rodent muscle
has been identiﬁed for several glycolytic and mitochondrial
enzymes, which are important for energy metabolism. The
glycolytic enzymes triosephosphate isomerase, glyoxalase I,
and β-enolase were downregulated in aged muscle. Other
features indicating perturbation of energy metabolism were
downregulation of creatine kinase, of pyruvate kinase, and
of the NADH-shuttle glycerol 3-phosphate dehydrogenase.
At the mitochondrial level, key enzymes such as isocitrate
dehydrogenase, cytochrome c oxidase, ATP synthase β
subunit, and pyruvate dehydrogenase were all decreased in
ageingmusclewhereastherewasanupregulationofaldehyde
dehydrogenase [26, 29, 35–38].
Diﬀerential proteomic analyses have revealed that ageing
is associated with perturbations of the myoﬁbrillar net-
work [26, 29, 35–38]. Notably, there is a downregulation
of several isoforms of myosin long chain and of alpha-
actin, as well as a diﬀerential expression of their major
regulators. In contrast to the downregulation of myoﬁbrillar
components, old muscles display upregulation of many
proteins of the intermediate ﬁlament, microtubules and
microﬁlament cytoskeleton, among which are B-tubulin,
desmin, and gelsolin. This suggests a mechanism aﬀecting
the cytoskeleton that compensates for perturbations in
myoﬁbrillar structure and so prevents extensive damage
to the myoﬁbers. Muscle ageing is also associated with
the diﬀerential expression of enzymes implicated in the
detoxiﬁcation of cytotoxic products. The cytoplasmic Cu/Zn
superoxide dismutase (SOD1) and H ferritin isoform, as well
as the levels of glutathione transferase and mitochondrial
aldehyde dehydrogenase, were found to be increased in older
rats, while evidence of age-associated protein misfolding
was provided by the upregulation of molecular chaperones
(including HSP 27 and disulﬁde isomerase ER60) [26, 29,
35–38].
Most of the proteins identiﬁed by diﬀerential proteomics
were previously unrecognized in ageing skeletal muscle.6 Journal of Biomedicine and Biotechnology
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Their identiﬁcation has not only provided further insight
into the potential mechanisms of ageing, but may lead to the
development of biomarkers of sarcopenia [26, 29, 35–38].
2.3. Proteomic Analysis Pertaining to Ageing Skeletal Muscle:
Analyses of Protein Phosphorylation, Nitration, and Glycosyla-
tion. Since posttranslational modiﬁcations are key modula-
tors of protein structure, function, signaling, and regulation,
various subdisciplines of proteomics have emerged that
focus on the cataloguing and functional characterization
of proteins with extensively modiﬁed side chains [57]. In
aged skeletal muscle, proteins undergo considerable changes
in their posttranslational modiﬁcations [58]. These include,
amongothers,phosphorylation,nitration,andglycosylation.
Phosphorylation representsone ofthe most frequentpeptide
modiﬁcations [59], and abnormal phosphorylation is associ-
ated with various pathologies. A recent phosphoproteomic
survey of aged muscle detected increased phosphorylation
levels for myosin light chain 2, tropomyosin α,l a c t a t e
dehydrogenase, desmin, actin, albumin, and aconitase [30].
In contrast, decreased phospho-speciﬁc dye binding was
observed for cytochrome c oxidase, creatine kinase, and
enolase. Thus, ageing-induced alterations in phosphopro-
teins appear to involve the contractile machinery and
the cytoskeleton, as well as cytosolic and mitochondrial
metabolism.
The nitration of protein tyrosine residues represents
an oxidative and important posttranslational modiﬁcation
occurring under nitrative/oxidative stress during biological
ageing. Comprehensive proteomic studies have identiﬁed an
age-related increase in the nitration of numerous skeletal
muscle proteins. These include enolase, aldolase, creatine
kinase, tropomyosin, glyceraldehyde-3-phosphate dehydro-
genase, myosin light chain, pyruvate kinase, actinin, actin,
and the ryanodine receptor [31, 32]. The nitration of these
essential muscle proteins may therefore be a signiﬁcant
causative factor in the age-related decline in muscle strength
[31, 32].
Glycosylation is one of the most frequent posttransla-
tional modiﬁcations found in proteins, and it plays a central
role in cellular mechanisms in both health and disease [60].
Oligosaccharide attachment represents a common protein
modiﬁcation that inﬂuences the folding of the nascent
peptide chain and the stability of glycoproteins, modi-
ﬁes enzymatic activity, controls protein-secretion events,
presents critical information about the cellular targeting of a
newly synthesized protein, and provides speciﬁc recognition
motifs for other proteins in cell-cell interactions [61]. The
identiﬁed muscle components belong mostly to the family
of metabolic enzymes. They included glycolytic enzymes,
such as pyruvate kinase, enolase, phosphoglycerate kinase,
aldolase, glyceraldehyde-3-phosphate dehydrogenase, and
phosphoglycerate-mutase, aconitase, carbonic anhydrase,
and creatine kinase [33].
These data conﬁrm that the sarcopenia of old age repre-
sents a complex neuromuscular pathology that is associated
with drastic changes not only in the abundance, but also in
the structure of key muscle proteins (Figure 2).
2.4. Proteomic Analysis Pertaining to Ageing Skeletal Muscle
Mitochondria. Analysis of the protein proﬁle of mitochon-
dria, and of the changes in it that occur with age, represents
a promising approach to the unraveling of the mechanisms
involved in ageing. Although the role of mitochondria
was long thought to be restricted to an inﬂuence on
fuel metabolism, the importance of the activity of these
organelles has recently been extended to the regulation
of developmental/ageing processes [62]. Mitochondria have
their own genome (mt-DNA) and speciﬁc mechanisms for
replication, transcription, and protein synthesis. However, in
terms of protein composition they are “hybrid” organelles
resulting from the coordinated expression of the nuclear
and their own genome. A bidirectional ﬂow of informa-
tion allows the two kinds of subcellular compartments
to communicate with each other under the control of
metabolic signals and several signal-transduction pathways
thatfunctionacrossthecell.Thesepathwaysarediﬀerentially
regulated by environmental and developmental signals, and
under patho/physiological conditions, they allow tissues to
adjust their energy production according to diﬀerent energy
demands possibly modulating/altering the mitochondrial
phenotype. It is now beyond doubt that mitochondria are
severely aﬀected by ageing, and it is generally believed that
dysfunctions of mitochondria trigger key steps in the ageing
process [62].
Mitochondrial proteomes (mitoproteomes) are currently
under vigorous investigation by way of both structural
and comparative proteomics. In particular, we would like
to emphasize the value of comparative proteomics as a
tool capable of providing us with valuable information on
mitochondrial physiology and on the role of these organelles
in ageing muscle. First, mitochondria can be highly puriﬁed,
leading to simpliﬁed 2D gels, which greatly facilitates the
analysis and detection of less-abundant proteins. Second,
mitochondrial proteins are generally distributed across wide
ranges of both pH and molecular mass on 2D gels,
leading to accurate protein resolution with only a few
protein-spot overlaps. Third, most of the mitochondrial
membrane-protein complexes exhibit soluble subunits that
can be analyzed on 2D gels even though the hydrophobic
subunits aggregate. Various detection methods are already
available that allow us to monitor quantitative changes in
the proteome. Of these, 2-DE-based methods appear quite
promising, with isoelectric focusing (IEF), BN-SDS, and
benzyldimethyl-nhexadecylammonium chloride (16-BAC)-
PAGE at the forefront. However, application of IEF is
restricted to proteins that are not highly hydrophobic or
have no extreme isoelectric points. Indeed, by the use
of classical 2D-E it is diﬃcult to detect very acidic or
very basic proteins or to distinguish small changes in the
expressions of weakly expressed proteins. On the other
hand, BN-SDS-PAGE deals eﬃciently with even hydropho-
bic membrane proteins, although some compromises in
resolution have to be made [63]. Another advantage of
the BN-PAGE system is the conservation of protein-
protein interactions, enabling simultaneous elucidation of
multimeric and multiprotein assemblies of soluble and
membrane proteins [64]. Such a procedure might be a8 Journal of Biomedicine and Biotechnology
viable alternative to other methods, such as yeast two-
hybridization.
Comparative transcriptomic and proteomic studies have
been initiated to determine global changes in mitochondria
from young versus aged skeletal muscle [26, 39, 41, 62,
65–68]. Native-diﬀerence gel electrophoresis (DIGE) is an
approach that facilitates sensitive quantitative assessment
of changes in membrane and soluble proteins. Recently,
O’Connell et al. [68] analyzed the mitochondria-rich frac-
tion from aged rat skeletal muscle by DIGE. This pro-
teomic analysis showed a clear age-related increase in key
mitochondrial proteins, such as NADH dehydrogenase, the
mitochondrial inner membrane protein mitoﬁlin, peroxire-
doxin isoform PRX-III, ATPase synthase, succinate dehy-
drogenase, mitochondrial ﬁssion protein Fis1, succinate-
coenzyme A ligase, acyl-coenzyme A dehydrogenase, porin
isoform VDAC2, ubiquinol-cytochrome c reductase core I
protein, and prohibitin [68].
Togaindeeperinsightsbothintoageingmechanismsand
into the resulting mitoproteome alterations, mitochondria
have been studied by the blue-native gel approach, both
with respect to protein abundance and the supramolecular
organization of OXPHOS complexes [26].
The proﬁles obtained for muscle crude mitochon-
dria from young and old rats—after detergent extrac-
tion with either dodecylmaltoside or digitonin, and sub-
sequent BN-PAGE—have been reported by us within
the past years [26]. The use of dodecylmaltoside allows
individual resolution of the respiratory complexes. Our
densitometric analysis revealed that gastrocnemius muscle
mitochondria from old rats, versus those from young
rats, contained signiﬁcantly lower amounts of complex
I (NADH:ubiquinone oxidoreductase), V (FoF1-ATP syn-
thase), and III (ubiquinol:cytochrome c oxidoreductase)
(−35%, −40%, −25%, resp.). The same mitochondria, on
the other hand, contained a signiﬁcantly larger amount of
complex II (succinate: ubiquinone oxidoreductase) (+25%)
and an unchanged amount of complex IV (cytochrome c
oxidase, COX). The use of a combination of BN-PAGE and
catalytic staining allowed us to detect reduced activity of all
the complexes in ageing muscle. The observed reductions
in the activities of respiratory complexes I, III, and V
reﬂected lower protein levels, but the reduction in complex
II activity was associated with an increase in the amount
of the same complex. To elucidate whether the ageing
process also alters the functional/structural organization of
the respiratory chain in terms of the assembly of supercom-
plexes,mitochondriawereextractedusingthemilddetergent
digitonin since this extensively retains inner mitochondrial
membrane supercomplexes [69]. In both young and old
mitochondria, monomeric complex I and dimeric complex
III were signiﬁcantly reduced versus dodecylmaltoside sol-
ubilization. However, the missing amounts were found to
be assembled in two major supercomplexes, a and b, and
two minor ones, c and d, all within the molecular mass
range of 1500–2100kDA. The supercomplex proﬁle of the
older rats was signiﬁcantly modiﬁed, band a being less
represented in the proﬁle than the heavier supercomplexes,
such as bands c and d. A signiﬁcant increase was detected in
the supramolecular assembly of respiratory chain complexes
into respirosomes (each one being formed by complex I
assembled with a dimeric complex III and a variable copy
number of complex IV, represented by bands c and d).
Possibly, this could be a compensatory mechanism that,
in ageing muscle, is functionally directed towards substrate
channeling and catalytic enhancement advantaging. Indeed,
mitochondrial oxidative phosphorylation seems to be more
eﬃcient in aged than in young skeletal muscle, since old
rats exhibited an increased respiratory control ratio that was
attributed principally to a reduction in the reactions able to
dissipate the proton motive force not associated with ATP
synthesis. This could be interpreted as a compensation for
the reduced level and activity of F1F0-ATP synthase.
The above data point up the ability of skeletal muscle to
face the consequences of ageing in a metabolically economic
wayandhighlighttheoccurrenceofstructuralandmetabolic
adaptations. A comparison between these two studies [26,
68] each employing diﬀerent proteomic approaches leads
to the conclusion that beyond the expression/abundance
changes in proteins, an insight can be obtained about the
structural and functional heterogeneity in a given mitopro-
teome.
Another possible protein modiﬁcation in skeletal muscle
mitochondria, possibly contributing to its functional decline
with age, is carbonylation, which can be considered an
oxidativemodiﬁcationthatmayrenderaproteinmoreprone
to degradation. Feng et al. [42] recently identiﬁed mito-
chondrial proteins that were susceptible to carbonylation
in a manner that was dependent on muscle type (slow-
versus fast-twitch) and on age. Carbonylated mitochondrial
proteins were more abundant in fast-twitch than in slow-
twitch muscle. Twenty-two proteins displayed signiﬁcant
changes in carbonylation state with age, the majority of
these increasing in their amount of carbonylation. Ingenuity
pathway analysis revealed that these proteins belong to
various functional classes and pathways, including cellular
function and maintenance, fatty acid metabolism, and the
citrate cycle. This study [42] provides a unique catalogue
of promising protein targets deserving further investigation
because of their potential role in the decline exhibited by
ageing muscle. Since carbonylation is not repairable, this
modiﬁcation may, however, be of special importance in
directingtheaﬀectedproteintothepathtowarddegradation.
Of note, in view of the importance of the functional
mitochondrial membrane compartmentalization, together
with proteomic approaches, lipidomic ones would be desir-
able to gain further insight into the understanding of the
modiﬁcation of lipids either as membrane components or
energy store following aging processes.
3. Thyroid Hormones and Thyroid States
Thyroid hormones [THs; 3,5,3 ,5 -tetraiodo-L-thyronine,
otherwise known as thyroxine (T4), and 3,5,3 -triiodo-L-
thyronine (T3)] are essential for the regulation both of
energy metabolism and of development and growth in all
vertebrates. In humans, the early developmental role of THsJournal of Biomedicine and Biotechnology 9
is vividly illustrated by the distinctive clinical features of
cretinism, as observed in iodine-deﬁcient areas. In adults,
the primary eﬀects of THs are manifested by alterations
in metabolism. Even subclinical hyper- and hypothyroidism
can have important consequences, such as atherosclerosis,
obesity, and alterations in bone mineral density and heart
rate [70, 71]. The eﬀects induced by THs in the regulation
of metabolism include changes in oxygen consumption and
in protein, carbohydrate, lipid, and vitamin metabolism.
Hyperthyroidism is associated with an increase (calorigenic
eﬀect), while hypothyroidism is associated with a decrease in
metabolicrate.Ofparticularnote,isthatthenumberandthe
complexity of the clinical features of hyperthyroidism and
hypothyroidism emphasize the pleiotropic eﬀects of THs on
many diﬀerent pathways and target organs. Although great
eﬀorts have been made to elucidate the signaling pathways
underlying the physiopathological eﬀects of thyroid hor-
mones,thenetworkoffactorsandcellulareventsinvolved, as
well as the possible role of derivatives of THs, is complicated
and incompletely understood, as is the ultimate eﬀect of THs
on tissue transcriptomes and proteomes.
3.1. The Complexity of Action of Thyroid Hormones: An
Overview. Most thyroid-related, direct genomic actions
leading to protein changes appear to be attributable to T3.
The mechanism of action that has gained general acceptance
forthisiodothyronineinvolvesthebindingofspeciﬁcnuclear
receptors (TRs) to thyroid hormone response elements
(TREs) in target genes [72]. Within the nucleus, TRs dimers
(hetero- or homodimers) bind to TREs and modulate gene
activity by either silencing or activating transcription by
recruitment of either corepressor or coactivator complexes,
depending on the absence or presence of thyroid hormone
[73–78]. In mammals, two genes encoding TRs have been
characterized, c-erb Aα and c-erb Aβ [79–81], and these
encode several proteins (α and β isoforms) with diﬀerent
binding properties and patterns of tissue expression. For
example, c-Erb Aβ1 is expressed across a wide range of
tissues, while c-ErbAβ2 is found almost exclusively in the
pituitary, where it inhibits thyrotrophin (TSH) α-a n dβ-
subunit gene transcription [82] by binding to negative TREs
present on these genes [83, 84]. New information on the
mechanisms of action of THs have been obtained from TR
gene knockout (KO) and knock-in studies [85].
In terms of cellular eﬀects, theories proposed so far to
explain the actions of THs on metabolic rate also include
mechanisms such as: uncoupling of oxidative phosphoryla-
tion, stimulation of energy expenditure by activation of Na+-
K+ ATPase activity, and direct modulation by THs of trans-
porters and enzymes located within the plasma membrane
and mitochondria [86–89]. Moreover, T3-mediated nuclear
gene expression leads in turn to coordinated and synergistic
eﬀects on the mitochondrial genome [90]. Actually, it
has been postulated that T3’s actions on this genome are
achieved through both an induction of nuclear-encoded
mitochondrial factors and a direct binding of T3 to speciﬁc
ligand-dependent mitochondrial transcription factors [90–
94]. These last are nuclear-receptor homologs and are
thought to act on a number of mt-DNA response elements
[95]. Indeed, T3 directly regulates the mitochondrial genes
encoding ATPase subunit six [96], NADH dehydrogenase
subunit three [97], and subunits of cytochrome-c-oxidase
[98].
The complexity of action of T3 is broadened by the
existenceofnongenomicorTRE-independentactions,which
have been extensively described and are now accepted [99].
Importantly, these can be either independent or dependent
on the binding of T3 to TRs. They occur rapidly and
are unaﬀected by inhibitors of transcription and protein
synthesis [90, 93, 100–102]. Nongenomic actions of thyroid
hormones have been described at the plasma membrane,
in the cytoplasm, and within cellular organelles ([100]a n d
references therein). These actions include modulations of
Na+,K +,C a 2+, and glucose transport, activations of PKC,
PKA, and ERK/MAPK, and regulation of phospholipid
metabolism via activations of PLC and PLD [103], and they
can be independent of the presence of nuclear TRs and
mediated even by TH analogs [102]. For example, it has
recently been shown that cytosolic TRβ can interact with the
p85 subunit of PI3K and thereby activate the PI3K-Akt/PKB
signaling cascade[99,104]. Moreover, it has beenshown that
THs activate the MAPK cascade and stimulate angiogenesis
via their binding to integrin α Vβ 3[ 100]. Importantly, it
appears now to be well established that an interplay exists
between the genomic and nongenomic actions when gene
expressionisregulatedbytheTR-T3complexandtheactivity
of the enzyme is modulated by a nongenomic process [100].
3.2. Transcriptomic Analysis Pertaining to the Actions of
Thyroid Hormones. Although the molecular actions of THs
have been thoroughly studied, their pleiotropic eﬀects are
not well understood and appear to be mediated by complex
changes in the expressions of numerous, but still largely
unknown, target genes in various tissues. DNA microarrays
have been successfully used to identify T3-target genes in
mouse, rat, and human tissues, cell lines, and tumors.
Actually, pioneering systematic studies in the search for T3-
target genes were performed by Seelig and coworkers as long
ago as 1981 [105].
Feng et al. [44] ﬁrst applied cDNA-microarray technol-
ogy to the study of the in vivo T3 regulation of hepatic
genes in the mouse. They identiﬁed new T3-target genes, the
majority of which had not previously been reported to be
regulated by the hormone. Surprisingly, many of these target
genes were negatively regulated. The identity of the genes
indicated that multiple cellular pathways are actuallyaﬀected
by T3, including glycogenolysis, gluconeogenesis, lipoge-
nesis, cell proliferation, apoptosis, the action of insulin,
immunogenicity, and protein glycosylation.
Weitzel et al. [49] detected novel T3-target genes and
identiﬁed two T3-mediated gene-expression patterns after
the administration of T3 to hypothyroid rats. In line with
the long-known observation that T3 has profound inﬂu-
ences over mitochondrial biogenesis and metabolic balance,
the authors reported that numerous genes implicated in
metabolic pathways (ANT2, apolipoprotein AIV, HMG-CoA10 Journal of Biomedicine and Biotechnology
synthase, and ATP synthase β subunit) are aﬀected by T3,
as also are genes associated with a wide variety of cellular
pathways (encompassing translation, protein turnover, cell
structure, and apoptosis-associated proteins). These obser-
vations gave support to the idea that alongside the “classical”
pathway of T3-mediated gene regulation (involving thyroid
hormone-receptor binding to TREs), there appears to be an
additional pathway mediated by transcription factors (such
as NRF-1 and PPARγ) and coactivators (such as the PGC-1
family of coactivators).
Flores-Morales et al. [45] veriﬁed the eﬀect of T3 on
liver in mice with a targeted mutation in the TRβ gene. In
accordancewiththeresultsofWeitzel[49],theyreportedthat
T3 regulates the expressions of functionally diﬀerent sets of
genesintemporallydistinctways.Importantly,usingTRβ−/−
animals they also deﬁned a number of T3-responsive genes
t h a ta r ed e p e n d e n to nT R β in vivo, thereby opening the way
for the use of similar experimental strategies to identify the
contributions made by speciﬁc transcription factors to the in
vivo actions of multiple hormones and trophic factors.
Miller et al. [50] identiﬁed genes involved in glucose
metabolism, biosynthesis, transcriptional regulation, protein
degradation,anddetoxiﬁcationthatwereassociatedwithT3-
induced cell proliferation. Of particular signiﬁcance were
the ﬁndings that T3 rapidly suppresses the expressions of
key regulators of the Wnt signaling pathway and that it
suppresses the transcriptional downstream elements of the
β-catenin-T-cell factor complex.
With the aim of deﬁning the molecular basis of the
target-tissue phenotype related to the hereditary TRβ muta-
tions causing resistance to thyroid hormone (RTH), Miller et
al. [46] showed that in T3-target tissues such as cerebellum,
heart, and WAT in animal models of both RTH and hyper-
thyroidism, T3 acts primarily to suppress gene expression,
andthatTRβhasagreatermodulatingeﬀectintheheartthan
originally thought. Moreover, their comprehensive multi-
tissue gene-expression analysis uncovered complex multiple
signaling pathways mediating the molecular actions of TRβ
mutants in vivo. It also revealed some T3-independent,
but mutant-dependent, genomic responses contributing to
those “changes-of-function” present in TRβ mutants that are
linked to the pathogenesis of RTH.
Dong et al. [48] studied the molecular mechanisms
involved in the responses shown by developing mice
to disruptions in maternal thyroid-hormone homeostasis.
Among diﬀerentially expressed genes, Nr4a1 (nuclear recep-
tor subfamily 4, group A, member 1), was upregulated by 3-
fold in the hypothyroid juvenile mouse liver, while treatment
of HepG2 cells with T3 resulted in its downregulation.
A potential thyroid response element −1218 to −1188bp
upstreamofthepromoterregionofNr4a1wasidentiﬁedand
demonstrated to bind TRα and TRβ receptors.
Notably,inrecentyearsmicroarrayapproacheshavebeen
used to characterize the eﬀects of T3 on gene expression
proﬁles in the postnatal developing brain as well as in the
adult mouse/rat brain [106–108].
The eﬀects of THs on gene expression proﬁles have been
studied less intensively in human tissues than in animal
above all because of the poor availability and accessibility
o ft i s s u e .H o w e v e r ,b o t hin vitro [51, 52]a n din vivo [53,
109] studies have been performed. Viguerie et al. [51], who
showed that T3 regulates a large repertoire of genes in
human adipocytes, provided support for the eﬀect of T3 on
catecholamine-induced lipolysis, and suggested downregu-
lation of SREBP1c as a link between hyperthyroidism and
insulin resistance. Moreover, in accordance with other array
studies, the data showed that thyroid hormone can aﬀect
cellular processes such as signal transduction, apoptosis,
and inﬂammatory responses. Moeller et al. [52] identiﬁed
91 T3-upregulated and 5 T3-downregulated genes in skin
ﬁbroblasts from normal humans. Some of these genes were
not previously known to be induced by T3, namely aldo-
keto reductase family 1 C1-3, collagen type VI alpha 3,
member RAS oncogene family brain antigen RAB3B, platelet
phosphofructokinase, hypoxia-inducible factor-1 alpha, and
enolase 1 alpha. Importantly, these genes have a variety of
regulatory functions in both development and metabolism.
Cl` ementetal.[53]studiedtheeﬀectsofthyroidhormone
on human skeletal muscle in vivo. Their data not only
helped to explain the eﬀects of T3 on protein turnover and
energy metabolism, but also revealed new putative mecha-
nisms extending beyond the classic metabolic eﬀects of the
hormone, and importantly, added to our understanding of
the permissive eﬀects of T3 on several cellular events (such
as signal-transduction cascades, intracellular transport, and
tissue remodeling).
Very recently, Visser et al. [54] examined the skeletal
muscle transcriptome in thyroidectomized patients being
treatedfordiﬀerentiatedthyroidcarcinoma,andcomparedit
between those who were oﬀ or on L-thyroxine replacement.
They reported for the ﬁrst time that in humans as in animals,
a large proportion of muscle genes (∼43%) is signiﬁcantly
downregulated by L-thyroxine treatment. They also reported
signiﬁcant regulation of the primary transcripts of the
noncoding RNAs miR-206 and miR-133b, which are key
regulators in muscle diﬀerentiation and proliferation and
may aﬀe c tn u m e r o u st a r g e tg e n e s .T h ep o t e n t i a lo fT 3t o
regulatemiRsmaybeofparticularimportancesincethislevel
of control would add an additional layer of complexity by
which T3 may regulate cellular processes.
Collectively, these studies (summarized in Table 3)h a v e
provided a cornucopia of novel information (schematized
in Figures 2 and 3) on the regulation of transcription by
THs. However, the intrinsic nature of these studies means
that they provide no information concerning the status of
the corresponding encoded proteins, and this is particularly
relevant because of the inﬂuence of thyroid hormone on
protein half-life.
3.3. Proteomic Analysis Pertaining to the Actions of Thyroid
Hormones. As stated above, overall T3 signaling can be
modulatedatmanylevels(i.e.,thethyroidhormone-receptor
isoforms present in the tissue, the DNA-response element
in the regulated gene, the availability of receptor-binding
partners, interactions with coactivators and corepressors,
ligand availability, mRNA and protein stabilities, protein
translocation, and metabolic interference) [72, 90–93]. Con-
sequently, for a deeper investigation of the biological eventsJournal of Biomedicine and Biotechnology 11
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M
u
r
i
n
e
n
o
n
-
t
r
a
n
s
f
e
c
t
e
d
h
e
p
a
t
o
c
y
t
e
c
e
l
l
l
i
n
e
A
M
L
1
2
,
e
x
p
r
e
s
s
i
n
g
e
n
d
o
g
e
n
o
u
s
T
R
s
.
R
N
A
o
b
t
a
i
n
e
d
f
r
o
m
c
e
l
l
s
i
n
c
u
b
a
t
e
d
f
o
r
3
h
o
u
r
s
o
r
2
4
h
o
u
r
s
+
/
−
1
0
n
M
T
3
,
i
n
t
h
e
p
r
e
s
e
n
c
e
o
f
1
0
%
s
t
r
i
p
p
e
d
f
e
t
a
l
b
o
v
i
n
e
s
e
r
u
m
.
C
e
l
l
s
a
l
s
o
i
n
c
u
b
a
t
e
d
i
n
t
h
e
p
r
e
s
e
n
c
e
o
f
c
y
c
l
o
h
e
x
i
m
i
d
e
(
1
0
`
ı
g
/
m
l
)
+
/
−
1
0
n
M
T
3
f
o
r
3
h
o
u
r
s
t
o
d
i
s
c
r
i
m
i
n
a
t
e
b
e
t
w
e
e
n
p
r
i
m
a
r
y
a
n
d
s
e
c
o
n
d
a
r
y
r
e
s
p
o
n
s
e
s
.
1
5
0
0
0
1
2
g
e
n
e
s
u
p
r
e
g
u
l
a
t
e
d
a
n
d
5
g
e
n
e
s
d
o
w
n
r
e
g
u
l
a
t
e
d
i
n
t
h
e
p
r
e
s
e
n
c
e
o
f
T
3
.
N
o
v
e
l
T
3
r
e
s
p
o
n
s
i
v
e
g
e
n
e
s
w
e
r
e
i
d
e
n
t
i
ﬁ
e
d
.
I
n
s
i
g
h
t
s
w
e
r
e
o
b
t
a
i
n
e
d
i
n
t
o
t
h
e
r
o
l
e
o
f
T
3
i
n
p
r
o
c
e
s
s
e
s
s
u
c
h
a
s
c
h
o
l
e
s
t
e
r
o
l
m
e
t
a
b
o
l
i
s
m
,
b
i
l
e
a
c
i
d
s
e
c
r
e
t
i
o
n
,
a
n
d
o
n
c
o
g
e
n
e
s
i
s
.
D
o
n
g
e
t
a
l
.
,
2
0
0
7
[
4
8
]
H
y
p
o
t
h
y
r
o
i
d
j
u
v
e
n
i
l
e
m
i
c
e
.
S
t
u
d
i
e
d
t
i
s
s
u
e
:
l
i
v
e
r
G
e
n
e
e
x
p
r
e
s
s
i
o
n
a
n
a
l
y
z
e
d
i
n
l
i
v
e
r
s
o
f
m
i
c
e
r
e
n
d
e
r
e
d
h
y
p
o
t
h
y
r
o
i
d
b
y
t
r
e
a
t
i
n
g
p
r
e
g
n
a
n
t
m
i
c
e
f
r
o
m
g
e
s
t
a
t
i
o
n
a
l
d
1
3
t
o
p
o
s
t
n
a
t
a
l
d
1
5
w
i
t
h
6
-
p
r
o
p
y
l
-
2
-
t
h
i
o
u
r
a
c
i
l
i
n
d
r
i
n
k
i
n
g
w
a
t
e
r
.
a
p
p
r
o
x
i
m
a
t
e
l
y
2
0
0
0
0
9
6
d
i
ﬀ
e
r
e
n
t
i
a
l
l
y
e
x
p
r
e
s
s
e
d
g
e
n
e
s
w
e
r
e
i
d
e
n
t
i
ﬁ
e
d
.
O
f
t
h
e
s
e
,
7
2
g
e
n
e
s
e
n
c
o
d
e
p
r
o
t
e
i
n
s
o
f
k
n
o
w
n
f
u
n
c
t
i
o
n
,
1
5
o
f
w
h
i
c
h
h
a
d
p
r
e
v
i
o
u
s
l
y
b
e
e
n
i
d
e
n
t
i
ﬁ
e
d
a
s
r
e
g
u
l
a
t
e
d
b
y
T
H
.
M
e
t
a
b
o
l
i
s
m
,
d
e
v
e
l
o
p
m
e
n
t
,
c
e
l
l
p
r
o
l
i
f
e
r
a
t
i
o
n
,
a
p
o
p
t
o
s
i
s
,
a
n
d
s
i
g
n
a
l
t
r
a
n
s
d
u
c
t
i
o
n
.
A
p
o
t
e
n
t
i
a
l
t
h
y
r
o
i
d
r
e
s
p
o
n
s
e
e
l
e
m
e
n
t
−
1
2
1
8
t
o
−
1
1
8
8
b
p
u
p
s
t
r
e
a
m
o
f
t
h
e
p
r
o
m
o
t
e
r
r
e
g
i
o
n
o
f
N
r
4
a
1
w
a
s
i
d
e
n
t
i
ﬁ
e
d
a
n
d
d
e
m
o
n
s
t
r
a
t
e
d
t
o
b
i
n
d
T
H
r
e
c
e
p
t
o
r
T
R
α
a
n
d
T
R
β
.
R
a
t
(
i
n
v
i
v
o
a
n
d
i
n
v
i
t
r
o
s
t
u
d
i
e
s
)
W
e
i
t
z
e
l
e
t
a
l
.
,
2
0
0
1
[
4
9
]
A
d
u
l
t
m
a
l
e
W
i
s
t
a
r
r
a
t
s
.
S
t
u
d
i
e
d
t
i
s
s
u
e
:
l
i
v
e
r
.
H
y
p
o
t
h
y
r
o
i
d
i
s
m
i
n
d
u
c
e
d
b
y
i
.
p
.
i
n
j
e
c
t
i
o
n
o
f
N
a
1
3
1
I
(
2
5
0
μ
C
i
/
1
0
0
g
b
o
d
y
w
e
i
g
h
t
)
2
8
d
a
y
s
b
e
f
o
r
e
t
h
e
e
x
p
e
r
i
m
e
n
t
s
.
H
y
p
e
r
t
h
y
r
o
i
d
i
s
m
p
r
o
v
o
k
e
d
b
y
i
.
p
.
i
n
j
e
c
t
i
o
n
o
f
T
3
(
5
0
μ
g
/
1
0
0
g
b
o
d
y
w
e
i
g
h
t
)
;
r
e
p
e
a
t
e
d
a
f
t
e
r
2
4
h
o
u
r
s
.
R
a
t
s
k
i
l
l
e
d
a
t
0
,
6
,
2
4
,
a
n
d
4
8
h
o
u
r
s
a
f
t
e
r
t
h
y
r
o
i
d
h
o
r
m
o
n
e
.
4
6
0
8
S
i
x
t
y
-
t
w
o
o
f
t
h
e
g
e
n
e
s
w
e
r
e
r
e
p
r
o
d
u
c
i
b
l
y
T
3
-
r
e
s
p
o
n
s
i
v
e
.
B
e
s
i
d
e
t
h
e
“
c
l
a
s
s
i
c
a
l
”
p
a
t
h
w
a
y
o
f
T
3
-
m
e
d
i
a
t
e
d
g
e
n
e
r
e
g
u
l
a
t
i
o
n
b
y
T
R
s
b
i
n
d
i
n
g
t
o
T
R
E
s
,
a
n
a
d
d
i
t
i
o
n
a
l
p
a
t
h
w
a
y
a
p
p
e
a
r
s
t
o
b
e
m
e
d
i
a
t
e
d
b
y
t
r
a
n
s
c
r
i
p
t
i
o
n
f
a
c
t
o
r
s
l
i
k
e
N
R
F
-
1
a
n
d
P
P
A
R
γ
a
n
d
c
o
a
c
t
i
v
a
t
o
r
s
(
l
i
k
e
t
h
e
P
G
C
-
1
f
a
m
i
l
y
o
f
c
o
a
c
t
i
v
a
t
o
r
s
)
.12 Journal of Biomedicine and Biotechnology
T
a
b
l
e
3
:
C
o
n
t
i
n
u
e
d
.
A
u
t
h
o
r
s
E
x
p
e
r
i
m
e
n
t
a
l
m
o
d
e
l
T
r
e
a
t
m
e
n
t
s
N
u
m
b
e
r
o
f
g
e
n
e
s
N
u
m
b
e
r
o
f
g
e
n
e
s
a
ﬀ
e
c
t
e
d
b
y
T
3
I
d
e
n
t
i
ﬁ
e
d
a
ﬀ
e
c
t
e
d
p
a
t
h
w
a
y
s
a
n
d
m
a
j
o
r
ﬁ
n
d
i
n
g
s
M
i
l
l
e
r
e
t
a
l
.
,
2
0
0
1
[
5
0
]
G
C
c
e
l
l
s
(
r
a
t
p
i
t
u
i
t
a
r
y
c
e
l
l
-
l
i
n
e
e
x
p
r
e
s
s
i
n
g
f
u
n
c
t
i
o
n
a
l
T
R
s
)
.
C
e
l
l
s
w
e
r
e
i
n
c
u
b
a
t
e
d
w
i
t
h
o
u
t
o
r
w
i
t
h
T
3
(
1
0
0
n
M
)
f
o
r
1
,
3
,
6
,
1
2
,
2
4
,
o
r
7
2
h
o
u
r
s
.
A
t
e
a
c
h
t
i
m
e
-
p
o
i
n
t
,
c
e
l
l
s
w
e
r
e
h
a
r
v
e
s
t
e
d
f
o
r
t
o
t
a
l
R
N
A
p
r
e
p
a
r
a
t
i
o
n
.
4
4
0
0
3
5
8
r
e
s
p
o
n
s
i
v
e
g
e
n
e
s
w
e
r
e
i
d
e
n
t
i
ﬁ
e
d
.
8
8
%
h
a
d
n
o
t
p
r
e
v
i
o
u
s
l
y
b
e
e
n
r
e
p
o
r
t
e
d
t
o
b
e
m
o
d
u
l
a
t
e
d
b
y
T
3
.
A
f
e
w
g
e
n
e
s
s
h
o
w
e
d
b
i
p
h
a
s
i
c
e
x
p
r
e
s
s
i
o
n
p
a
t
t
e
r
n
s
.
I
n
t
o
t
a
l
,
2
0
3
g
e
n
e
s
w
e
r
e
u
p
r
e
g
u
l
a
t
e
d
a
n
d
t
h
e
r
e
m
a
i
n
d
e
r
w
e
r
e
d
o
w
n
r
e
g
u
l
a
t
e
d
b
y
T
3
.
G
l
u
c
o
s
e
m
e
t
a
b
o
l
i
s
m
,
b
i
o
s
y
n
t
h
e
s
i
s
,
t
r
a
n
s
c
r
i
p
t
i
o
n
a
l
r
e
g
u
l
a
t
i
o
n
,
p
r
o
t
e
i
n
d
e
g
r
a
d
a
t
i
o
n
,
a
n
d
d
e
t
o
x
i
ﬁ
c
a
t
i
o
n
i
n
T
3
-
i
n
d
u
c
e
d
c
e
l
l
p
r
o
l
i
f
e
r
a
t
i
o
n
.
H
u
m
a
n
(
i
n
v
i
v
o
a
n
d
i
n
v
i
t
r
o
s
t
u
d
i
e
s
)
V
i
g
u
e
r
i
e
a
n
d
L
a
n
g
i
n
,
2
0
0
3
[
5
1
]
H
u
m
a
n
a
d
i
p
o
s
e
t
i
s
s
u
e
o
b
t
a
i
n
e
d
f
r
o
m
t
h
e
s
.
c
.
a
b
d
o
m
i
n
a
l
f
a
t
d
e
p
o
t
s
o
f
C
a
u
c
a
s
i
a
n
w
o
m
e
n
f
o
r
c
D
N
A
a
r
r
a
y
a
n
d
R
T
c
o
m
p
e
t
i
t
i
v
e
P
C
R
e
x
p
e
r
i
m
e
n
t
s
.
S
u
r
g
i
c
a
l
a
d
i
p
o
s
e
t
i
s
s
u
e
s
a
m
p
l
e
s
w
e
r
e
d
i
s
s
e
c
t
e
d
f
r
o
m
s
k
i
n
a
n
d
v
e
s
s
e
l
s
,
a
n
d
c
u
l
t
u
r
e
d
a
d
i
p
o
c
y
t
e
s
w
e
r
e
o
b
t
a
i
n
e
d
.
C
u
l
t
u
r
e
s
w
e
r
e
t
r
e
a
t
e
d
w
i
t
h
T
3
(
1
0
0
n
m
)
o
r
v
e
h
i
c
l
e
f
o
r
2
4
h
o
u
r
s
.
M
e
d
i
u
m
-
f
r
e
e
T
3
c
o
n
c
e
n
t
r
a
t
i
o
n
w
a
s
m
e
a
s
u
r
e
d
a
t
1
a
n
d
2
4
h
o
u
r
s
a
f
t
e
r
a
d
d
i
t
i
o
n
o
f
T
3
(
u
s
i
n
g
R
I
A
k
i
t
s
)
.
1
1
7
6
A
m
o
n
g
t
h
e
s
t
a
t
i
s
t
i
c
a
l
l
y
s
i
g
n
i
ﬁ
c
a
n
t
c
h
a
n
g
e
s
i
n
m
R
N
A
l
e
v
e
l
s
o
f
m
o
r
e
t
h
a
n
1
.
3
-
f
o
l
d
,
1
3
a
n
d
6
g
e
n
e
s
w
e
r
e
p
o
s
i
t
i
v
e
l
y
o
r
n
e
g
a
t
i
v
e
l
y
r
e
g
u
l
a
t
e
d
,
r
e
s
p
e
c
t
i
v
e
l
y
.
S
i
g
n
a
l
t
r
a
n
s
d
u
c
t
i
o
n
,
l
i
p
i
d
m
e
t
a
b
o
l
i
s
m
,
a
p
o
p
t
o
s
i
s
,
a
n
d
i
n
ﬂ
a
m
m
a
t
o
r
y
r
e
s
p
o
n
s
e
s
.
M
o
e
l
l
e
r
e
t
a
l
.
,
2
0
0
5
[
5
2
]
S
k
i
n
ﬁ
b
r
o
b
l
a
s
t
s
o
f
n
o
r
m
a
l
i
n
d
i
v
i
d
u
a
l
s
.
H
u
m
a
n
s
k
i
n
w
a
s
o
b
t
a
i
n
e
d
b
y
p
u
n
c
h
b
i
o
p
s
y
f
r
o
m
t
h
r
e
e
n
o
r
m
a
l
i
n
d
i
v
i
d
u
a
l
s
a
n
d
t
w
o
p
a
t
i
e
n
t
s
w
i
t
h
R
T
H
.
F
i
b
r
o
b
l
a
s
t
s
w
e
r
e
g
r
o
w
n
i
n
s
u
p
p
l
e
m
e
n
t
e
d
w
i
t
h
1
0
%
b
o
v
i
n
e
c
a
l
f
s
e
r
u
m
(
B
C
S
)
.
A
t
c
o
n
ﬂ
u
e
n
c
y
,
t
h
e
m
e
d
i
u
m
w
a
s
r
e
p
l
a
c
e
d
w
i
t
h
o
n
e
c
o
n
t
a
i
n
i
n
g
T
H
-
d
e
p
l
e
t
e
d
B
C
S
(
T
x
B
C
S
)
,
o
b
t
a
i
n
e
d
f
r
o
m
a
t
h
y
r
o
i
d
e
c
t
o
m
i
z
e
d
c
a
l
f
.
F
o
r
m
i
c
r
o
a
r
r
a
y
s
,
i
n
c
u
b
a
t
i
o
n
w
i
t
h
T
3
w
a
s
f
o
r
2
4
h
o
u
r
s
.
m
o
r
e
t
h
a
n
1
5
0
0
0
M
i
c
r
o
a
r
r
a
y
a
n
a
l
y
s
i
s
i
d
e
n
t
i
ﬁ
e
d
1
4
8
g
e
n
e
s
i
n
d
u
c
e
d
b
y
1
.
4
-
f
o
l
d
o
r
m
o
r
e
a
n
d
ﬁ
v
e
g
e
n
e
s
r
e
p
r
e
s
s
e
d
t
o
0
.
7
o
r
l
e
s
s
2
4
h
o
u
r
s
a
f
t
e
r
t
r
e
a
t
m
e
n
t
w
i
t
h
2
×
1
0
−
9
M
T
3
.
T
a
k
i
n
g
i
n
t
o
a
c
c
o
u
n
t
d
u
p
l
i
c
a
t
e
g
e
n
e
s
,
t
h
e
s
e
r
e
p
r
e
s
e
n
t
e
d
9
1
u
p
-
r
e
g
u
l
a
t
e
d
a
n
d
ﬁ
v
e
d
o
w
n
r
e
g
u
l
a
t
e
d
g
e
n
e
s
,
r
e
s
p
e
c
t
i
v
e
l
y
.
A
l
d
o
-
k
e
t
o
r
e
d
u
c
t
a
s
e
f
a
m
i
l
y
1
C
1
-
3
,
c
o
l
l
a
g
e
n
t
y
p
e
V
I
α
3
,
m
e
m
b
e
r
R
A
S
o
n
c
o
g
e
n
e
f
a
m
i
l
y
b
r
a
i
n
a
n
t
i
g
e
n
R
A
B
3
B
,
p
l
a
t
e
l
e
t
p
h
o
s
p
h
o
f
r
u
c
t
o
k
i
n
a
s
e
,
h
y
p
o
x
i
a
-
i
n
d
u
c
i
b
l
e
f
a
c
t
o
r
-
1
α
,
a
n
d
e
n
o
l
a
s
e
1
α
g
e
n
e
s
,
p
r
e
v
i
o
u
s
l
y
k
n
o
w
n
t
o
b
e
i
n
d
u
c
e
d
b
y
T
H
,
w
e
r
e
i
d
e
n
t
i
ﬁ
e
d
a
n
d
v
a
l
i
d
a
t
e
d
.
T
h
e
s
e
g
e
n
e
s
h
a
v
e
a
v
a
r
i
e
t
y
o
f
r
e
g
u
l
a
t
o
r
y
f
u
n
c
t
i
o
n
s
i
n
d
e
v
e
l
o
p
m
e
n
t
a
n
d
m
e
t
a
b
o
l
i
s
m
.
C
l
`
e
m
e
n
t
e
t
a
l
.
,
2
0
0
2
[
5
3
]
H
e
a
l
t
h
y
m
a
l
e
C
a
u
c
a
s
i
a
n
v
o
l
u
n
t
e
e
r
s
(
2
2
–
3
3
y
e
a
r
s
o
l
d
)
.
T
h
e
s
a
m
e
i
n
v
e
s
t
i
g
a
t
i
o
n
s
w
e
r
e
p
e
r
f
o
r
m
e
d
o
n
d
a
y
0
a
n
d
d
a
y
1
4
.
S
t
u
d
i
e
d
t
i
s
s
u
e
:
v
a
s
t
u
s
l
a
t
e
r
a
l
i
s
m
u
s
c
l
e
b
y
p
e
r
c
u
t
a
n
e
o
u
s
b
i
o
p
s
i
e
s
.
P
a
r
t
i
c
i
p
a
n
t
s
t
o
o
k
o
n
e
t
a
b
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Figure 3: Overview of the main T3-induced transcriptomic and proteomic alterations occurring in mammalian liver. Schematic
representation of the alterations in gene/protein expression underlying the response of liver to T3. Schematized are the main events
and mechanisms underlying the actions of T3. Summarized are data obtained in cDNA microarray/proteomic-based studies in various
mammalian models (mouse, rat, and human) (for details, see text and Tables 3 and 4).
modulated by T3 within target organs, a systematic analysis
of the T3-induced changes in protein proﬁle would appear to
be appropriate.
We recently performed, on samples taken from rats
in diﬀerent thyroid states, high-resolution diﬀerential pro-
teomic analysis, combining 2D-E and subsequent MALDI-
ToF MS [55,56].Thesestudies(summarizedinTable 4)w er e
the ﬁrst application of proteomic technology to the study of
the modulations that T3 exerts in vivo over tissue proteins,
and they provided the ﬁrst systematic identiﬁcation of T3-
induced changes in the protein expression proﬁles of rat liver
andskeletalmuscle.Intheliver,weunambiguouslyidentiﬁed
14 diﬀerentially expressed proteins involved in substrate and
lipid metabolism, energy metabolism, detoxiﬁcation of cyto-
toxic products, calcium homeostasis, amino acid catabolism,
and the urea cycle [55]. We found that T3 treatment
aﬀected the expressions of enzymes such as mitochondrial
aldehyde dehydrogenase, α-enolase, sorbitol dehydrogenase,
acyl-CoA dehydrogenase, 3-ketoacyl-CoA thiolase, and 3-
hydroxyanthranilate 3,4-dioxygenase. Interestingly, the ﬁrst
two enzymes were upregulated, while the others were
downregulated.
Our data were in accordance with the reported role
played by thyroid hormone in the stimulation of the rate of
ethanol elimination [110], and they provided further insight
into the mechanisms actuated by T3 in that pathway. T3 is
known to stimulate gluconeogenesis and glucose production
in the liver, thereby opposing the action of insulin on
hepatic glucose production [111]. Our results extended this
knowledge by showing that T3 signiﬁcantly enhances the
level of α-enolase, thereby participating in glycolysis and
gluconeogenesis. In addition, T3 administration induced a
signiﬁcant increase in the hepatic ATP synthase α-chain con-
tent (in accordance with the ability of T3 to stimulate ATP
synthesis) and concomitantly reduced the expression level of
electron transfer ﬂavoprotein α-subunit (α-ETF), and also
that of the acyl-CoA dehydrogenases [112]. T3 treatment is
associated with signiﬁcant reductions in the expression levels
of both peroxisomal catalase and cytoplasmic glutathione-
S-transferase [55], the former being important in the pro-
tection of cells against the toxic eﬀects of hydrogen peroxide
while the latter is implicated in the cellular detoxiﬁcation of
a number of xenobiotics by means of their conjugation to
reduced glutathione. T3 treatment of hypothyroid rats is also
associated with a selective upregulation of HSP60, a molecu-
larchaperone[113].SMP30,alsoknownasregucalcin,which
was previously not known to be aﬀected by T3, has now been
identiﬁed as a T3 target [55]. This opens new perspectives
in our understanding of the molecular pathways related to
intracellular T3-dependent signaling, raising the possibility
that T3 may modulate a plethora of cellular events while also
acting on multifunctional proteins such as SMP30, which in
turn is able to modulate the levels of second messengers such
as calcium.14 Journal of Biomedicine and Biotechnology
Table 4: Summary of the models used and of the major ﬁndings obtained by applying 2D-E and MS to the study of THs eﬀects.
Authors Experimental
model Treatments
Number of
protein spots
analyzed
Number of
identiﬁed
proteins aﬀected
by T3
Identiﬁed aﬀected pathways and
major ﬁndings
Rat
Silvestri et al.,
2006 [55]
3-months-
old male
Wistar rats.
Studied
tissue: liver.
Hypothyroidism was induced
by i.p. administration of PTU
(1mg/100g BW) for 4 weeks
together with a weekly i.p.
injection of IOP (6mg/100g
BW). T3 was chronically
administered by giving seven
daily i.p. injections of 15μg
T3/100g BW to hypothyroid
rats, while the control
euthyroid and hypothyroid
rats received saline injections.
600 14
The whole cell protein content of
rat liver was analyzed following
T3 administration. Identiﬁed
proteins were involved in
substrates and lipid metabolism,
energy metabolism,
detoxiﬁcation of cytotoxic
products, calcium homeostasis,
amino acid catabolism, and the
urea cycle.
Silvestri et al.,
2007 [56]
3-months-
old male
Wistar rats.
Studied
tissue:
skeletal
muscle.
Hypothyroidism and
hyperthyroidism were
induced as above (Silvestri et
al 2006 [55]).
220 20
The whole-cell protein content of
gastrocnemius muscles was
analyzed. The diﬀerentially
expressed proteins
unambiguously identiﬁed were
involved in substrates and energy
metabolism, stress response, cell
structure, and gene expression.
T3-treated rats exhibit signiﬁcant reductions in the
protein levels of both ornithine carbamoyltransferase and
arginase 1 [55]. These data are in accordance with a previous
report[114],andinlinewiththeideathatinthehypothyroid
state there are decreases in protein synthesis and turnover.
Concerning skeletal muscle, the whole-cell protein con-
tent of gastrocnemius muscle has been analyzed, and twenty
diﬀerentially expressed proteins among euthyroid, hypothy-
roid, and hyperthyroid rats have been identiﬁed [56]. The
largest group of aﬀected proteins (50%) was involved in
substrate and energy metabolism, another important group
was represented by stress-induced proteins (HSPs) (21.4%),
and the remainder were implicated in structural features or
gene expression (transcription, translation), each of these
two groups representing 14.3% of the identiﬁed proteins
[56]. The thyroid state was found to induce structural shifts
in gastrocnemius muscle, toward a slower phenotype in
hypothyroidism and toward a faster phenotype in hyperthy-
roidism [56].
Among the proteins involved in substrate metabolism,
three glycolytic enzymes have been identiﬁed, namely, beta-
enolase, pyruvate kinase, and triosephosphate isomerase.
Beta-enolase protein levels were increased following T3
treatment (hyperthyroidism), while pyruvate kinase and
triosephosphate isomerase levels were decreased in hypothy-
roidism and elevated in hyperthyroidism [56]. This is in
accordance with (a) a major T3-dependence on pyru-
vate kinase and triosephosphate isomerase and a generally
decreased metabolic dependence on glycolysis in hypothy-
roidism, and (b) an increased reliance on glycolysis in
hyperthyroidism [115]. Accordingly, hyperthyroidism was
found to be associated with an increased expression of
cytoplasmic malate dehydrogenase. Moreover, phosphat-
idylethanolamine-bindingprotein,abasicproteinthatshows
preferential aﬃnity in vitro for phosphatidylethanolamine,
was signiﬁcantly increased in both the hypo- and hyper-
thyroid gastrocnemius (versus the euthyroid controls), most
likely reﬂecting a thyroid state-associated cell-remodeling
[56].
The expression level of the ATP synthase beta subunit
was increased in both hypothyroid and hyperthyroid muscle
(versus euthyroid controls), with a slight decrease in hyper-
thyroid animals versus hypothyroid ones. Cytosolic creatine
kinase, on the other hand, was decreased in hypothyroidism
versus both euthyroidism and hyperthyroidism, suggesting a
decreased dependence of energy metabolism on the creatine
kinase shuttle in hypothyroid muscle [56].
The expression level of HSP70 was found to be sig-
niﬁcantly increased in hypothyroid muscle (versus both
euthyroid and hyperthyroid muscle), paralleling the changes
in MHCIb [56]. A similar expression pattern was found for
HSP20 which, despite not being a heat-inducible HSP, is
biologically regulated by several cellular signalling pathways.
Also identiﬁed was HSP27, which has been demonstrated
to play important roles in smooth muscle cells (actin
polymerization, remodeling, and even cross-bridge cycling),
andwhichcan,moreover,actasachaperoneintheregulation
of contractile-protein activation [116] and also combat
insulin resistance [117].
Concerningcellstructure,inaccordancewithapredomi-
nant expression of MHCIb over MHCIIb in hypothyroidism
and a reversal of the ratio between the two ﬁber-typeJournal of Biomedicine and Biotechnology 15
isoforms after T3 administration, the expression level of
myosin regulatory light chain 2, typical of slow-twitch
ﬁbers,wasstronglyincreasedinhypothyroidism,withhyper-
thyroidism signiﬁcantly reducing it (in each case, versus
euthyroidism) [56].
Finally, both hypothyroidism and hyperthyroidism
induced chromodomain-helicase-DNA-binding protein 1
(CHD 1), as well as eukaryotic translation initiation factor
3 subunit 10 (IF3A), two proteins that play important
roles in diﬀerent steps of gene expression: (1) initiation of
transcription; and (2) initiation of translation [56].
4. Conclusions
In conclusion, although the biochemical and cellular mech-
anisms that underlie sarcopenia in ageing muscle and the
eﬀects elicited by thyroid hormones are only beginning to be
elucidated, array-based transcriptomic studies, together with
MS-based proteomic ones, are producing new insights into
the pathophysiological mechanisms behind such complex
phenomena.
As can be seen from the above discussion, the approaches
used in the cited studies have allowed the identiﬁcation
of previously unrecognized proteins, thereby increasing our
awarenessofthelargerepertoireofproteins,andthemultiple
cell processes and signaling pathways that are aﬀected by T3
and by ageing (for a schematic representation, see Figures
2 and 3). However, as the majority of the cited studies
were performed in vivo, the possibility remains that certain
hormones and/or other factors that are aﬀected by such
metabolic situations may have been partially responsible for
the observed results.
On the basis of what has been achieved so far, the
authors feel justiﬁed in championing the use of combined
transcriptomic and proteomic approaches in living ani-
mals for the study of complex physiological, as well as
pathophysiological, systems. Such approaches should also
prove valuable for drug-design, enabling the agonist and/or
antagonist properties of drugs (as well as their side eﬀects) to
be characterized on the basis of the changes they induce in
protein-expression patterns.
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